SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-044618
Filing Date
2023-08-25
Accepted
2023-08-25 17:01:03
Documents
7
Effectiveness Date
2023-08-25

Document Format Files

Seq Description Document Type Size
1 S-8 form_s-8.htm S-8 177431
2 OPINION OF OSLER, HOSKIN & HARCOURT LLP acst-ex5_1.htm EX-5.1 13862
3 CONSENT OF ERNST & YOUNG LLP acst-ex23_1.htm EX-23.1 5002
4 CONSENT OF KPMG LLP acst-ex23_2.htm EX-23.2 7401
5 EX-FILING FEES acst-exfiling_fees.htm EX-FILING FEES 26167
6 GRAPHIC img206583140_0.jpg GRAPHIC 4192
7 GRAPHIC img206583140_1.jpg GRAPHIC 20579
  Complete submission text file 0000950170-23-044618.txt   265296
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-274228 | Film No.: 231209149
SIC: 2834 Pharmaceutical Preparations